Sweden - Sweden - Läkemedelsverket (Medical Products Agency)

glenmark pharmaceuticals s.r.o. - mometasonfuroatmonohydrat; olopatadinhydroklorid - nässpray, suspension - 25 mikrogram/dos + 600 mikrogram/dos - mometasonfuroatmonohydrat 25,86 mikrog aktiv substans; etanol, vattenfri hjälpämne; olopatadinhydroklorid 665 mikrog aktiv substans; bensalkoniumklorid hjälpämne

Sweden - Sweden - Läkemedelsverket (Medical Products Agency)

laboratoires thea - ketotifenvätefumarat - Ögondroppar, lösning - 0,25 mg/ml - glycerol hjälpämne; ketotifenvätefumarat 0,345 mg aktiv substans - ketotifen

Sweden - Sweden - Läkemedelsverket (Medical Products Agency)

2care4 aps - modafinil - tablett - 100 mg - laktosmonohydrat hjälpämne; modafinil 100 mg aktiv substans

Kesatuan Eropah - Sweden - EMA (European Medicines Agency)

sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningit, meningokock - vacciner - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.

Sweden - Sweden - Läkemedelsverket (Medical Products Agency)

aop orphan pharmaceuticals gmbh - naltrexonhydroklorid - filmdragerad tablett - 50 mg - naltrexonhydroklorid 50 mg aktiv substans; laktosmonohydrat hjälpämne - naltrexon